Globalstar, Inc.
Globalstar, Inc. (GSAT) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Globalstar, Inc. (GSAT), covering cash flow, earnings, and balance sheets.
Globalstar, Inc. (GSAT) Income Statement & Financial Overview
Explore comprehensive income reports for Globalstar, Inc. GSAT, broken down by year and quarter.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $60.03M | $61.18M | $72.31M | $60.38M |
Cost of Revenue | $20.67M | $21.98M | $2.52M | $42.29M |
Gross Profit | $39.36M | $39.20M | $69.79M | $18.09M |
Gross Profit Ratio | $0.66 | $0.64 | $0.97 | $0.30 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $18.55M | $20.90M | $18.69M | $19.52M |
Operating Expenses | $47.86M | $43.45M | $41.17M | $41.63M |
Total Costs & Expenses | $68.53M | $65.43M | $62.87M | $61.81M |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $7.95M | $0.00 | $0.00 | $3.64M |
Depreciation & Amortization | $22.28M | $22.53M | $22.25M | $22.11M |
EBITDA | $20.81M | $18.30M | $31.91M | $20.69M |
EBITDA Ratio | $0.35 | $0.30 | $0.44 | $0.34 |
Operating Income | -$8.50M | -$4.25M | $9.43M | -$1.42M |
Operating Income Ratio | -$0.14 | -$0.07 | $0.13 | -$0.02 |
Other Income/Expenses (Net) | -$4.25M | -$45.76M | $2.23M | -$8.08M |
Income Before Tax | -$12.75M | -$50.006M | $11.67M | -$9.50M |
Income Before Tax Ratio | -$0.21 | -$0.82 | $0.16 | -$0.16 |
Income Tax Expense | $4.58M | $213000.00 | $1.73M | $182000.00 |
Net Income | -$17.33M | -$50.22M | $9.93M | -$9.68M |
Net Income Ratio | -$0.29 | -$0.82 | $0.14 | -$0.16 |
EPS | -$0.16 | -$0.42 | $0.004 | -$0.005 |
Diluted EPS | -$0.16 | -$0.42 | $0.004 | -$0.005 |
Weighted Avg Shares Outstanding | $126.48M | $126.23M | $189.23M | $188.42M |
Weighted Avg Shares Outstanding (Diluted) | $126.48M | $126.23M | $191.006M | $188.42M |
The company's financials show resilient growth, with revenue advancing from $60.38M in Q2 2024 to $60.03M in Q1 2025. Gross profit remained healthy with margins at 66% in Q1 2025 compared to 30% in Q2 2024. Operating income hit -$8.50M last quarter, sustaining a consistent -14% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $20.81M. Net income rose to -$17.33M, while earnings per share reached -$0.16. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan